Newcare Clinics Of Baxter in Baxter, IA - Clinic/Center

Newcare Clinics Of Baxter is a primary clinic (Clinic/center - Rural Health) in Baxter, Iowa. The current practice location for Newcare Clinics Of Baxter is 208 E Buchanan St, Baxter, Iowa. For appointments, you can reach them via phone at (641) 227-3045. The mailing address for Newcare Clinics Of Baxter is 208 E Buchanan St, Baxter, Iowa and phone number is () -.

Newcare Clinics Of Baxter is licensed to practice in * (Not Available) (license number ) and its NPI number is 1447511068. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (641) 227-3045.

Contact Information

	Newcare Clinics Of Baxter
	208 E Buchanan St Baxter IA 50028-1002
	(641) 227-3045
	Not Available

Primary Care Clinic Profile

Full Name	Newcare Clinics Of Baxter
Speciality	Clinic/center - Rural Health
Location	208 E Buchanan St, Baxter, Iowa
Authorized Official Name and Position	Todd C Burch (CLINIC MANAGER)
Authorized Official Contact	6412041936
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Newcare Clinics Of Baxter 208 E Buchanan St Baxter IA 50028-1002 Ph: () -	Newcare Clinics Of Baxter 208 E Buchanan St Baxter IA 50028-1002 Ph: (641) 227-3045

NPI Details:

NPI Number	1447511068
Provider Enumeration Date	05/30/2012
Last Update Date	05/30/2012

Medical Identifiers

Medical identifiers for Newcare Clinics Of Baxter such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1447511068	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261QP2300X	Clinic/center - Primary Care	(* (Not Available))	Secondary
261QR1300X	Clinic/center - Rural Health	(* (Not Available))	Primary

News Archive

Investment report on Generex Biotechnology from MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Generex Biotechnology Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

FDA advises consumers, health care professionals about Xenical, Alli

The U.S. Food and Drug Administration today advised consumers and health care professionals about potential rare occurrences of severe liver injury in patients taking the weight-loss medication orlistat, marketed as Xenical and Alli.

New findings offer promising druggable target to root out metastatic pancreatic cancer

Cancer of the pancreas is a deadly disease, with a median survival time of less than six months. Only one in 20 people with pancreatic cancer survives five years past the diagnosis. The reason is the cancer's insidiousness; tumor cells hide deep inside the body, betraying no symptoms until late in the disease, when the cancer has almost invariably spread to other organs.

Drug company coalition to push for looser rules on off-label marketing

Representatives of health care marketing firms, patient advocacy groups and pharmaceutical companies this week are in Washington, D.C., to express support for loosening rules regarding drug companies' ability to market medications for off-label uses, the Wall Street Journal reports (Mundy, Wall Street Journal, 4/18).

Innovative tool could redefine limits of synthetic biology, improve study of yeast genetics

NYU Langone yeast geneticists report they have developed a novel tool - dubbed "the telomerator" - that could redefine the limits of synthetic biology and advance how successfully living things can be engineered or constructed in the laboratory based on an organism's genetic, chemical base-pair structure.

Newcare Clinics Of Baxter - Primary Care in Baxter, IA